Gujral Jaspreet S, Knight Tamara R, Farhood Anwar, Bajt Mary Lynn, Jaeschke Hartmut
Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, 4301 W. Markham St. (Mailslot 638), Little Rock, AR 72205, USA.
Toxicol Sci. 2002 Jun;67(2):322-8. doi: 10.1093/toxsci/67.2.322.
Acetaminophen (AAP) overdose can cause severe liver injury and liver failure in experimental animals and humans. Recently, several authors proposed that apoptosis might be a major mechanism of cell death after AAP treatment. To address this controversial issue, we evaluated a detailed time course of liver injury after AAP (300 mg/kg) in fasted C3Heb/FeJ mice. Apoptotic hepatocytes were quantified in H&E-stained liver sections using morphologic criteria (cell shrinkage, chromatin condensation and margination, and apoptotic bodies). The number of apoptotic hepatocytes remained at baseline (0.2 +/- 0.1 cells/10 high-power fields [HPF]) up to 2 h after AAP administration. However, between 3 and 24 h, apoptotic cell death increased significantly, e.g., 6.3 +/- 0.8 cells/10 HPF at 6 h. Despite the increase in the number of hepatocytes meeting the morphological criteria of apoptosis, this cell fraction remained well below 1% of all parenchymal cells. No evidence for caspase-3 processing or increase in enzyme activity was detected at any time. These results were compared to the overall percent of necrotic cells in liver sections. Confluent areas of centrilobular necrosis were estimated to involve 40-60% of all hepatocytes between 3 and 24 h after AAP administration. These numbers correlated with the increase in plasma alanine aminotransferase activities, which reached a peak level of 5900 +/- 1350 U/l at 24 h. A similar result was obtained with higher doses of AAP and with the use of fed animals. Thus, oncotic necrosis and not apoptosis is the principal mechanism of liver-cell death after AAP overdose in vivo.
对乙酰氨基酚(AAP)过量服用可在实验动物和人类中导致严重肝损伤和肝衰竭。最近,几位作者提出凋亡可能是AAP处理后细胞死亡的主要机制。为解决这一有争议的问题,我们评估了禁食的C3Heb/FeJ小鼠经AAP(300mg/kg)处理后肝损伤的详细时间进程。使用形态学标准(细胞皱缩、染色质凝聚和边缘化以及凋亡小体)对苏木精-伊红(H&E)染色的肝切片中的凋亡肝细胞进行定量。给予AAP后2小时内,凋亡肝细胞数量维持在基线水平(0.2±0.1个细胞/10个高倍视野[HPF])。然而,在3至24小时之间,凋亡细胞死亡显著增加,例如在6小时时为6.3±0.8个细胞/10个HPF。尽管符合凋亡形态学标准的肝细胞数量增加,但该细胞比例仍远低于所有实质细胞的1%。在任何时间均未检测到半胱天冬酶-3的加工或酶活性增加的证据。将这些结果与肝切片中坏死细胞的总体百分比进行比较。据估计,在给予AAP后3至24小时之间,中央小叶坏死的融合区域累及所有肝细胞的40%-60%。这些数字与血浆丙氨酸转氨酶活性的增加相关,其在24小时时达到峰值水平5900±1350U/L。使用更高剂量的AAP以及对喂食的动物进行实验也得到了类似结果。因此,在体内AAP过量服用后,胀亡性坏死而非凋亡是肝细胞死亡的主要机制。